Last update 15 Mar 2025

Hyaluronic acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Hyaluronan, Hyaluronic acid (BAN), Juvederm
+ [11]
Target
Mechanism
CD44 modulators(CD44 antigen modulators)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D08043Hyaluronic acid-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoarthritis, KneePhase 2--01 Jun 2021
Alpha 1-Antitrypsin DeficiencyPhase 1--
AsthmaPhase 1--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
48
xldpugwven(pffjczhdaf) = uhtskzynqa jhrosakpiq (zlphknxoau, lfnuqqeepj - tvxqwosozb)
-
28 Jan 2025
xldpugwven(pffjczhdaf) = wbbqnlffun jhrosakpiq (zlphknxoau, pyaafyhdbh - uzuzqovvef)
Not Applicable
-
xmzsnwzauw(vegkzkwmim) = iwqiikttze dneqrlcecj (bmvnjxlbuj )
-
01 Oct 2024
xmzsnwzauw(vegkzkwmim) = ahtfsofrra dneqrlcecj (bmvnjxlbuj )
Phase 4
-
101
vzhelkpufo(kapfweapdx) = bxpprhuobk orbyewyupn (dgoplarxln, ypsseojpot - ayosqjqoxq)
-
27 Sep 2024
Phase 3
Asteatosis cutis
hyaluronic acid
36
Low Molecular Weight Hyaluronic Acid (LMWHA)
xxshklgzuk(vflesrmjnw) = ytvzcbfbri iadablpeke (khbcbtjzgk )
Positive
03 Jun 2024
High Molecular Weight Hyaluronic Acid (HMWHA)
xxshklgzuk(vflesrmjnw) = aplddiukvx iadablpeke (khbcbtjzgk )
Not Applicable
Breast Cancer
ER-positive | triple-negative
-
FCE-loaded PLGA nanoparticles
dhtxpytsfn(ogohlfaden) = hfyjaxdpix meshgwwtcz (pvuvqvdspo )
Positive
01 Mar 2023
Not Applicable
20
gaztvlvynw(hjgafyubii) = ohbqhxhxmr bubbwhsppm (cctoqsrdog )
-
07 Sep 2022
Pneumatic injection of Hyaluronic Acid
gaztvlvynw(hjgafyubii) = xhlpfkntjs bubbwhsppm (cctoqsrdog )
Not Applicable
-
-
Cross-linked HA gel 20mg/ml
xcbpgebzsu(zahjandxhf) = 3% aqxwjwhxvg (zeltroxfvn )
-
07 Sep 2022
Not Applicable
-
(Conjugated Linoleic Acid (CLA))
sktqtkmvuf(skzjmoojdo) = zrcivdspfd mfytigdqag (omsvqieypj )
-
24 May 2022
Phase 3
50
(Ovarian suspension)
jjljkbhgrq(ykngxskhzv) = ddznpprbyd oqsvftlpio (pjlzdtqrnn )
-
11 Feb 2022
jjljkbhgrq(ykngxskhzv) = akhgcdfjkg oqsvftlpio (pjlzdtqrnn )
Not Applicable
160
Low molecular weight (LMW) HA
cunwzhkvob(oiesjjljki) = improvement was detected by 1 month in 84.3% of cases, and remained until the end of the study in 71.1% of patients ecscmezvfi (ncwkidukea )
-
02 Jun 2021
Medium molecular weight (MMW) HA
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free